RecruitingPhase 3NCT06919965
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
Studying Muscular tumor
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Janssen Research & Development, LLC
- Principal Investigator
- Janssen Research & Development, LLC Clinical TrialJanssen Research & Development, LLC
- Intervention
- TAR-210(drug)
- Enrollment
- 220 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2025 – 2032
Study locations (30)
- Colorado Clinical Research, Lakewood, Colorado, United States
- Georgia Urology, Atlanta, Georgia, United States
- Associated Urological Specialists, Chicago Ridge, Illinois, United States
- Urology of Indiana, Carmel, Indiana, United States
- Greater Boston Urology, Plymouth, Massachusetts, United States
- Comprehensive Urology, Royal Oak, Michigan, United States
- UroHealth Partners, Omaha, Nebraska, United States
- New Jersey Urology LLC, Voorhees Township, New Jersey, United States
- Associated Medical Professionals, Syracuse, New York, United States
- Dayton Physicians Network Urology, Centerville, Ohio, United States
- The Urology Group, Cincinnati, Ohio, United States
- Helios Clinical Research, LLC, Middleburg Heights, Ohio, United States
- Oregon Urology Institute, Springfield, Oregon, United States
- MidLantic Urology, Bala-Cynwyd, Pennsylvania, United States
- Keystone Urology Specialists, Lancaster, Pennsylvania, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06919965 on ClinicalTrials.govOther trials for Muscular tumor
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07144319Exploration of Novel AI-enabled Blue Light Enhanced CystoscopyPhotocure
- RECRUITINGPHASE2NCT07475403Urinary Tumor DNA-Guided Systemic Immunotherapy for Unresectable Very-High-Risk Non-Muscle-Invasive Bladder CancerTianjin Medical University Second Hospital
- RECRUITINGPHASE2NCT07475806A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their BladderAstellas Pharma Global Development, Inc.
- RECRUITINGNANCT07431788The Effect of Uterine Manipulator Use During Abdominal Hysterectomy on Postoperative Sexual FunctionErkan Gol
- RECRUITINGNANCT07339761Supporting Sexual Health in Bladder Cancer Patients: A Sequential Mixed-Methods Intervention StudyUniversity of Aarhus
- RECRUITINGPHASE2NCT07363057A Study to Evaluate the Effects of the Combination of GI-102 With GIB-7 on Biomarkers of Aging in Healthy Adults and Cancer SurvivorsGI Innovation, Inc.
- ACTIVE NOT RECRUITINGNANCT07001670Investigation of the Effects of Tele-Yoga Training in Individuals With Lung Cancer Undergoing Lung Resection SurgeryIstanbul University
- RECRUITINGNANCT06940310Different Resistance Training Intensity Prescription and Monitoring Methodologies: Effects on Strength, Body Composition, and Well-being in Survivors of Breast CancerUniversidad de Almeria